The efficiency of chronic disease care in sub-Saharan Africa by Pascal Geldsetzer et al.
COMMENTARY Open Access
The efficiency of chronic disease care in
sub-Saharan Africa
Pascal Geldsetzer1, Katrina Ortblad1 and Till Bärnighausen1,2,3*
Abstract
The number of people needing chronic disease care is projected to increase in sub-Saharan Africa as a result of
expanding human immunodeficiency virus (HIV) treatment coverage, rising life expectancies, and lifestyle changes.
Using nationally representative data of healthcare facilities, Di Giorgio et al. found that many HIV clinics in Kenya,
Uganda, and Zambia appear to have considerable untapped capacity to provide care for additional patients. These
findings highlight the potential for increasing the efficiency of clinical processes for chronic disease care at the
facility level. Important questions for future research are how estimates of comparative technical efficiency across
facilities change, when they are adjusted for quality of care and the composition of patients by care complexity.
Looking ahead, substantial research investment will be needed to ensure that we do not forgo the opportunity to
learn how efficiency changes, as chronic care is becoming increasingly differentiated by patient type and integrated
across diseases and health systems functions.
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Evolving health systems for chronic care in
sub-Saharan Africa
The disease burden of chronic non-communicable
diseases (NCD) is increasing in sub-Saharan Africa
(SSA), while the burden attributable to acute infectious
diseases is on the decline [1]. In the midst of this
epidemiological transition, increased access to effective
antiretroviral therapy (ART) is transforming human
immunodeficiency virus (HIV) infection from a disease
that cuts life expectancy by decades to a chronic afflic-
tion that does not substantially reduce life expectancy
[2, 3]. As a result, the number of people needing chronic
disease care continues to grow in the region [1, 4], call-
ing into question the capacity of the generally weak
health systems in SSA to effectively treat and support all
patients needing chronic care [5, 6]. As ART continues
to be scaled up with expanded eligibility [7], this strain
on health systems in SSA will likely continue to increase
over the coming decades [7].
The health system challenges posed by the continuously
increasing number of patients with HIV have spurred
efforts to assess the efficiency of current models of HIV
care as well as to develop new, more efficient models of
care. HIV and NCD share many health system challenges
in terms of the successful implementation of primary pre-
vention, screening, and early linkage to care; monitoring
of therapeutic success; and the need for long-term medi-
cation adherence. Thus, research on the efficiency of
health systems in delivering HIV care will also provide
crucial lessons for health systems to help them success-
fully address the expected rise in the burden of NCD. This
commentary discusses the recent article by Di Giorgio et
al. in BMC Medicine [8], and future areas of research that
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Untapped capacity in health systems in
sub-Saharan Africa
The study by Di Giorgio et al. suggests that the health
systems in Kenya, Uganda, and Zambia have considerable
capacity to deliver HIV care to more patients without add-
ing labor and capital inputs [8]. In fact, the authors
estimate that the current systems could deliver care to an
additional 459,000 patients with HIV– a 40 % increase in
the current HIV patient volume. These findings imply that
many healthcare facilities in the study countries have
untapped capacity to deal with not only higher volumes of
HIV patients, but also increased demand for other types
of chronic disease care.
Thus far, policy and research in the field of healthcare
delivery in SSA has largely been concerned either with
inducing demand for healthcare, or, more recently,
improving the quality of care on the supply side. The
study by Di Giorgio et al. is an important contribution
to this field because it points to a research and policy
area that has received little attention thus far: supply-
side interventions at the level of the healthcare facility to
increase the efficiency of care.
We see two important methods improvements to
increase the robustness of this research: controlling for
quality of care and controlling for patient composition
when measuring efficiency of care. We also see the
emergence of a new focus in health systems research:
experiments and quasi-experiments to establish the
causal impact of changing models of care on efficiency.
Efficiency and quality of care
As healthcare facilities increase the quantity of care with
a fixed level of inputs, quality of care may deteriorate.
For instance, healthcare workers may have less time
available to spend per patient, resulting in lower diag-
nostic accuracy and reduced patient satisfaction. One
important area of future research will thus be to care-
fully assess the degree to which the volume of chronic
care patients can be increased without adversely affect-
ing quality of care and patient outcomes. Owing to data
constraints, Di Giorgio et al. were only able to include
structural indicators of care quality provided by health-
care facilities (e.g., the availability of certain medica-
tions). Future research in this area should control for
outcome quality of care in the comparison of efficiency
of care across facilities, including objective outcome
quality (e.g., viral load suppression for HIV care,
hemoglobin A1c for diabetes care) and subjective out-
come quality (e.g., overall patient satisfaction with care).
In addition, time-and-motion studies can provide in-
sights into process aspects of quality of care by enumer-
ating the health worker activities during the patient
encounter and the time spent per activity [9].
Patient composition
Patients in advanced disease stages or those with comor-
bidities are likely to demand more human resource inputs
(in terms of both health worker time and skill level) and
other inputs (e.g., blood tests) than healthier patients. The
composition of the patient population – that is, the distri-
bution of patients across ‘complex’ and ‘simple’ patient
types – is therefore likely to have profound effects on the
quantity of patients any given number of health workers
can provide with high-quality care. Because patient
composition is likely to vary between healthcare facilities,
and at facilities over time, it will be important for future
research on chronic care efficiency in SSA to adjust effi-
ciency estimates for patient composition. Indicators of pa-
tient complexity will need to be carefully constructed to
avoid systematic misclassification of complexity by quality
of care. For instance, CD4-cell count is both an indicator
of quality of care for patients with HIV, as well as a meas-
ure of HIV disease severity and thus patient complexity.
While adjustments for patient composition will require
additional data collection and research investments, we
would argue that these adjustments are essential to accur-
ately determine which healthcare facilities operate at the
production possibility frontier and which are less efficient.
New models of care
Recently, there has been a proliferation of new HIV care
models, which provide varying levels of intensity and
types of care to different categories of patients. Such
models may deliver increased levels of facility-based care
to some patients, such as adherence support for those
who first present to HIV programs while feeling well [7].
However, for those who are clinically stable on ART,
differentiated HIV care models usually aim to reduce
patient volumes at healthcare facilities. Examples of such
models are less frequent clinic appointments, the deliv-
ery of antiretroviral drugs (ARV) to patients’ homes,
peer educator-led ARV refill groups, and community
ARV distribution points [7, 10]. The finding by Di Gior-
gio et al. of untapped capacity in the current standard
facility-based models of HIV care should be viewed in
the context of these emerging models, which often aim
to increase the efficiency of HIV care by decongesting
healthcare facilities. Many of the new models are still in
the development stage and have yet to be evaluated
rigorously and at scale [10]. Measuring quality of care
will be particularly critical in these evaluations because, in
the new models of HIV care, highly qualified or
specialized (and thus expensive) healthcare resources –
such as nurses – are often replaced by less qualified or
specialized (and thus less expensive) resources – such as
community health workers. If the quality of HIV care
using the new models of HIV care is at least equal to the
quality of care delivered using the current models, the
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new models will be more efficient and should thus be-
come the preferred approach.
Another change in HIV care in SSA is the joint delivery
of HIV and NCD treatment in integrated models of chronic
care [11]. Such integration is likely to affect efficiency of
care in complex ways whose net effects are hard to predict
and thus need to be empirically determined. From the
perspective of the patient, integrated models of chronic care
are likely efficiency-enhancing because they create a ‘one-
stop shop’ for multiple chronic care needs (such as for HIV,
diabetes, hypertension, and depression [12, 13]), lowering
the number of healthcare visits each patient has to make
and thus reducing average out-of-pocket expenditures and
lost time from work to seek care [14]. The potential for
such patient-centered efficiency gains is likely to increase
over the coming decades as continuously rising ART cover-
age will increase the co-prevalence of HIV and NCD. This
increase will be driven by a new epidemiological transition
in SSA through several important pathways [2] (Geldsetzer
et al. in press): ART allows patients with HIV to survive
into the older ages when NCD become very common [3];
the aging process in people surviving on ART is accelerated
by chronic HIV inflammation that is not eliminated
by ART [15–17]; and several ARVs have side effects
that cause NCD [18].
From the perspective of the health system, the impact of
integrating HIV care with other health system functions is
less clear. On the one hand, integration of care could re-
duce clinicians’ efficiency, because it decreases
specialization and increases task switching costs, as sug-
gested by classic division labor theory [19–21]. On the
other hand, integration could also improve the efficiency
of the health system through the joint utilization of fixed
factors of production (e.g., clinics) and sharing of health
system functions (e.g., monitoring and evaluation systems)
[22]. In addition, it has been argued that integration will
improve the quality of care through a shift from disease-
to more person-centered healthcare [6], resulting in more
trusting relationships between patient and health worker,
and health workers who are more familiar with a patient’s
multiple healthcare needs.
Conclusions
The increasing demand for chronic diseases is a formidable
challenge to health systems in SSA. Finding ways to
improve efficiency of chronic disease care while maintain-
ing or even increasing quality of care will be crucial. The
empirical literature on this topic is astoundingly sparse; yet,
the answers to many of the key questions on the efficiency
of novel models for chronic care are far from obvious.
Thus, we agree with Davies and colleagues who have re-
cently concluded in a commentary on the future of chronic
disease care in SSA that “[t]he lynchpin of a successful
effort to grow health systems that can deal with communic-
able diseases and NCDs equally effectively is research” [23].
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